Pharmacokinetic enhancement of HIV antiretroviral therapy during pregnancy
Pharmacokinetic boosting of antiretroviral (ARV) therapies with either ritonavir or cobicistat
is used to achieve target drug exposure, lower pill burden, and provide simplified dosing …
is used to achieve target drug exposure, lower pill burden, and provide simplified dosing …
Modifying antiretroviral therapy in virologically suppressed HIV-1-infected patients
SE Collins, PM Grant, RW Shafer - Drugs, 2016 - Springer
HIV-1-infected patients with suppressed plasma viral loads often require changes to their
antiretroviral (ARV) therapy to manage drug toxicity and intolerance, to improve adherence …
antiretroviral (ARV) therapy to manage drug toxicity and intolerance, to improve adherence …
Women and HIV: motherhood and more
J Anderson - Current opinion in infectious diseases, 2012 - journals.lww.com
Efficacious anti-HIV drugs exist, but the particular circumstances for women may
compromise their effectiveness. Globally, women's access to therapy remains inadequate …
compromise their effectiveness. Globally, women's access to therapy remains inadequate …
HIV: the changing paradigm
S Raubinger, FJ Lee, AN Pinto - Internal Medicine Journal, 2022 - Wiley Online Library
The past four decades have seen enormous progress in the diagnosis and management of
human immunodeficiency virus (HIV) infection. There have been significant advances …
human immunodeficiency virus (HIV) infection. There have been significant advances …
Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants
E Chiappini, L Galli, C Giaquinto, L Ene… - Aids, 2013 - journals.lww.com
Objectives: To evaluate use of combination neonatal prophylaxis (CNP) in infants at high
risk for mother-to-child transmission (MTCT) of HIV in Europe and investigate whether CNP …
risk for mother-to-child transmission (MTCT) of HIV in Europe and investigate whether CNP …
Antiretroviral prescribing practices among pregnant women living with HIV in the United States, 2008-2017
Importance Since 1994, the US Department of Health and Human Services has published
treatment guidelines for pregnant women living with HIV. Understanding how well …
treatment guidelines for pregnant women living with HIV. Understanding how well …
[HTML][HTML] Cobicistat as a pharmacoenhancer in pregnancy and postpartum: progress to date and next steps
AC Eke, MH Mirochnick - Journal of clinical pharmacology, 2019 - ncbi.nlm.nih.gov
Combination antiretroviral therapy with fixed-dose drug combinations (FDCs) that allow for
once-daily, single-tablet regimens for the management of HIV infection, are now available …
once-daily, single-tablet regimens for the management of HIV infection, are now available …
Migrant women living with HIV in Europe: are they facing inequalities in the prevention of mother-to-child-transmission of HIV? The European Pregnancy and …
G Favarato, H Bailey, F Burns, L Prieto… - … European Journal of …, 2018 - academic.oup.com
Background In pregnancy early interventions are recommended for prevention of mother-to-
child-transmission (PMTCT) of HIV. We examined whether pregnant women who live with …
child-transmission (PMTCT) of HIV. We examined whether pregnant women who live with …
Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery
K Aebi-Popp, F Mulcahy, TR Glass… - JAIDS Journal of …, 2013 - journals.lww.com
Methods: In a pooled analysis of data on HIV-positive pregnant women enrolled in the Swiss
Mother & Child HIV Cohort Study and the European Collaborative Study 2000 to 2010 …
Mother & Child HIV Cohort Study and the European Collaborative Study 2000 to 2010 …
Human immunodeficiency virus viral load rebound near delivery in previously suppressed, combination antiretroviral therapy–treated pregnant women
I Boucoiran, AYK Albert, K Tulloch… - Obstetrics & …, 2017 - journals.lww.com
OBJECTIVE: To assess the stability of human immunodeficiency virus (HIV) viral load
suppression within 1 month before birth in pregnant women receiving antenatal combination …
suppression within 1 month before birth in pregnant women receiving antenatal combination …